D Plocová Selected Research

Breast Neoplasms (Breast Cancer)

1/2002

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Plocová Research Topics

Disease

8	Neoplasms (Cancer) 04/2008 - 02/2000
3	Melanoma (Melanoma, Malignant) 02/2004 - 01/2001
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2008 - 01/2002
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2002 - 02/2000
1	T-Cell Leukemia (Leukemia, T Cell) 04/2008
1	Lymphoma (Lymphomas) 04/2008
1	Neuroblastoma 02/2004
1	Breast Neoplasms (Breast Cancer) 01/2002
1	B-Cell Leukemia (Leukemia, B Cell) 01/2002
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Colorectal Neoplasms (Colorectal Cancer) 09/2000

Drug/Important Bio-Agent (IBA)

5	PolymersIBA 04/2008 - 09/2000
4	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2008 - 02/2000
4	hydroxypropyl methacrylateIBA 04/2008 - 02/2000
3	ribonuclease SPLIBA 02/2004 - 01/2001
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 02/2004 - 05/2002
2	Monoclonal AntibodiesIBA 01/2002 - 09/2000
1	EnzymesIBA 02/2004
1	Ribonucleases (Ribonuclease)IBA 02/2004
1	methacrylamideIBA 05/2002
1	Immunoglobulin G (IgG)IBA 01/2002
1	N-(2-hydroxypropyl)methacrylamideIBA 01/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2002
1	BuffersIBA 01/2001
1	OligopeptidesIBA 01/2001
1	SolutionsIBA 01/2001
1	EstersIBA 01/2001
1	Peanut AgglutininIBA 09/2000
1	Drug CarriersIBA 09/2000
1	Plant LectinsIBA 09/2000
1	Wheat Germ AgglutininsIBA 09/2000
1	XenobioticsIBA 09/2000
1	LectinsIBA 09/2000
1	GalactosamineIBA 09/2000
1	Proteins (Proteins, Gene)FDA Link 02/2000
1	Immunologic Factors (Immunomodulators)IBA 02/2000
1	AntibodiesIBA 02/2000
1	Cell Surface ReceptorsIBA 02/2000

Therapy/Procedure

3	Therapeutics 09/2000 - 02/2000